Extracellular S100A1 protein inhibits apoptosis in ventricular cardiomyocytes via activation of the extracellular signal-regulated protein kinase 1/2 (ERK1/2)
about
sameAs
S100A1 is released from ischemic cardiomyocytes and signals myocardial damage via Toll-like receptor 4S100A1 in cardiovascular health and disease: closing the gap between basic science and clinical therapyS100A1: Structure, Function, and Therapeutic PotentialS100A1: A novel and essential molecular component for postischemic angiogenesisS100A1: a multifaceted therapeutic target in cardiovascular diseaseCardiac adenoviral S100A1 gene delivery rescues failing myocardiumPolybromo protein BAF180 functions in mammalian cardiac chamber maturationS100A1: a regulator of striated muscle sarcoplasmic reticulum Ca2+ handling, sarcomeric, and mitochondrial functionOrai1 and Stim1 regulate normal and hypertrophic growth in cardiomyocytes.Gene delivery approaches to heart failure treatment.S100A1 (S100 calcium binding protein A1)Sorcin modulates mitochondrial Ca(2+) handling and reduces apoptosis in neonatal rat cardiac myocytes.Gene transfer for congestive heart failure: update 2013.S100A1: a novel inotropic regulator of cardiac performance. Transition from molecular physiology to pathophysiological relevance.S100B: a multifunctional role in cardiovascular pathophysiology.Phospholipase C as a potential target for cardioprotection during oxidative stress.Cardiac gene therapy: from concept to reality.The S100 protein family and its application in cardiac diseases.RAGE mediates podocyte injury in adriamycin-induced glomerulosclerosisG protein-coupled receptor kinase 2 promotes cardiac hypertrophyCardiac gene therapy: are we there yet?Connecting myelin-related and synaptic dysfunction in schizophrenia with SNP-rich gene expression hubs.Cardiac Overexpression of S100A6 Attenuates Cardiomyocyte Apoptosis and Reduces Infarct Size After Myocardial Ischemia-Reperfusion.An efficient expression and purification strategy for the production of S100 proteins in Escherichia coli.Subtype-specific differentiation of cardiac pacemaker cell clusters from human induced pluripotent stem cells.Upregulation of paxillin and focal adhesion signaling follows Dystroglycan Complex deletions and promotes a hypertensive state of differentiation.Lack of S100A1 in mice confers a gender-dependent hypertensive phenotype and increased mortality after myocardial infarction.Intracellular and Extracellular Effects of S100B in the Cardiovascular Response to Disease.Ca2+ -dependent interaction of S100A1 with F1-ATPase leads to an increased ATP content in cardiomyocytesVEGF-PLCgamma1 pathway controls cardiac contractility in the embryonic heart.S100 protein family and its application in clinical practice.S100 Proteins As an Important Regulator of Macrophage Inflammation.
P2860
Q28240188-D345C397-C224-4264-9A56-A57527E1DF1BQ28249115-AB380487-3DD4-4DDC-AF80-53EA83C4AD32Q28263662-76321346-0AD6-4E9D-99A8-7D0A87B6926DQ28282541-E09F2954-3CF0-4F1F-B6FA-33474C0AE96AQ28288362-424C3199-8AF1-4D39-BA60-422F1084AEEDQ28296403-8B18195E-D4B4-4AA3-A1E0-EF512F5973FEQ28591027-9A12CA38-2C7D-4204-83D0-2617B63D0C47Q33757903-0B636D73-79D2-47DB-85F8-F351F62C7BC9Q33906288-0CBF5582-B448-44CF-9B38-F0B64583D1DBQ35873759-36BF8975-505C-4ABC-9199-66BB9E65FCE6Q35879854-931A8F3E-0A70-482E-A3EB-0906A49F10EDQ36592853-764D9B25-2FA0-4B4A-A2B1-09C0712FD8FDQ36698991-DCEB8E81-0E88-4F92-B552-D6131D9A088DQ36801998-BD68E169-B561-4A77-9D1F-F90056806941Q37702852-F6353F73-3BC5-4DBE-A874-59AD0048703CQ37731344-63A4C259-085D-4C73-B8E8-A74E891413E0Q37965045-72993721-A2BF-4B4F-85D0-AFE3C68A491BQ38248594-A2BD850C-0D9E-4B2D-8163-681FF9DC2072Q38528738-697C6669-3EC7-4CD1-94CB-8C99495272E8Q38651555-274E2F63-2108-42BC-AC14-96DC1C205C39Q38820937-6AFA2DB2-8645-41AA-8C6A-E37821F3A8A6Q38850829-24932260-C3AB-4BD6-B19A-1A76A2E9E9D3Q41102519-4ABB4EA6-76E9-49EB-8552-DBED60A73970Q41844120-B7DDF194-80BB-4450-9625-0A5E4E702688Q42379230-0F22928D-A8C8-4259-B6F7-3F9A1C1BB8B9Q42386051-0FA1EA9B-D8E1-4381-B090-214E2FCEF82AQ42450906-9E19D0A0-8446-4DB5-BEF2-F69225D4BB32Q42579440-BE981BA4-B146-4109-9347-AB98CDEF1F6DQ42738033-3113A4B3-9809-4F59-B3CB-BC7BCFD49333Q42915525-B71D1F2A-7EE3-4B6C-90E2-059677D06222Q43245445-C61C0377-6B52-4342-9398-4505CA1A43F2Q49497885-79FDA824-ECC0-487D-95A6-FCE99FF447CB
P2860
Extracellular S100A1 protein inhibits apoptosis in ventricular cardiomyocytes via activation of the extracellular signal-regulated protein kinase 1/2 (ERK1/2)
description
2003 nî lūn-bûn
@nan
2003 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Extracellular S100A1 protein i ...... ed protein kinase 1/2 (ERK1/2)
@ast
Extracellular S100A1 protein i ...... ed protein kinase 1/2 (ERK1/2)
@en
Extracellular S100A1 protein i ...... ed protein kinase 1/2 (ERK1/2)
@nl
type
label
Extracellular S100A1 protein i ...... ed protein kinase 1/2 (ERK1/2)
@ast
Extracellular S100A1 protein i ...... ed protein kinase 1/2 (ERK1/2)
@en
Extracellular S100A1 protein i ...... ed protein kinase 1/2 (ERK1/2)
@nl
prefLabel
Extracellular S100A1 protein i ...... ed protein kinase 1/2 (ERK1/2)
@ast
Extracellular S100A1 protein i ...... ed protein kinase 1/2 (ERK1/2)
@en
Extracellular S100A1 protein i ...... ed protein kinase 1/2 (ERK1/2)
@nl
P2093
P2860
P356
P1476
Extracellular S100A1 protein i ...... ed protein kinase 1/2 (ERK1/2)
@en
P2093
Andrew Remppis
Carmen Eicher
Christopher Schweda
Cora-Ann Schoenenberger
Eva Loeffler
Hugo A Katus
Patrick Most
Philipp Ehlermann
Sven T Pleger
Walter J Koch
P2860
P304
P356
10.1074/JBC.M308587200
P407
P577
2003-11-28T00:00:00Z